Letter abstract


Nature Medicine 13, 975 - 980 (2007)
Published online: 5 August 2007 | doi:10.1038/nm1616

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

Kenshi Yamasaki1, Anna Di Nardo1, Antonella Bardan1, Masamoto Murakami2, Takaaki Ohtake3, Alvin Coda1, Robert A Dorschner1, Chrystelle Bonnart4,5, Pascal Descargues4,5, Alain Hovnanian4,5,6, Vera B Morhenn1 & Richard L Gallo1


Acne rosacea is an inflammatory skin disease that affects 3% of the US population over 30 years of age and is characterized by erythema, papulopustules and telangiectasia1, 2, 3. The etiology of this disorder is unknown, although symptoms are exacerbated by factors that trigger innate immune responses, such as the release of cathelicidin antimicrobial peptides4. Here we show that individuals with rosacea express abnormally high levels of cathelicidin in their facial skin and that the proteolytically processed forms of cathelicidin peptides found in rosacea are different from those present in normal individuals. These cathelicidin peptides are a result of a post-translational processing abnormality associated with an increase in stratum corneum tryptic enzyme (SCTE) in the epidermis. In mice, injection of the cathelicidin peptides found in rosacea, addition of SCTE, and increasing protease activity by targeted deletion of the serine protease inhibitor gene Spink5 each increases inflammation in mouse skin. The role of cathelicidin in enabling SCTE-mediated inflammation is verified in mice with a targeted deletion of Camp, the gene encoding cathelicidin. These findings confirm the role of cathelicidin in skin inflammatory responses and suggest an explanation for the pathogenesis of rosacea by demonstrating that an exacerbated innate immune response can reproduce elements of this disease.

Top
  1. Division of Dermatology, University of California, San Diego, and VA San Diego Health Care System, 3350 La Jolla Village Drive, San Diego, California 92161, USA.
  2. Department of Dermatology, Asahikawa Medical College, Asahikawa 078-8510, Japan.
  3. Department of Medicine, Asahikawa Medical College, 2-1-1-1 Midorigacka Hidashi, Asahikawa 078-8510, Japan.
  4. INSERM, U563, Toulouse F-31000, France.
  5. Université Paul-Sabatier, Toulouse F-31000, France.
  6. CHU Toulouse, Department of Genetics, Place du Dr. Baylac, Toulouse F-31000, France.

Correspondence to: Richard L Gallo1 e-mail: rgallo@ucsd.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Rosacea: skin innate immunity gone awry?

Nature Medicine News and Views (01 Aug 2007)

Shigellae control the Gates of LL

Nature Medicine News and Views (01 Feb 2001)